MedTech Responds to the Coronavirus - UPDATE
Friday, March 13, 2020
Source: MedTech Association
Friends and Colleagues:
When I communicated with you last Friday about MedTech’s response to the COVID-19 pandemic, I told you that we are committed to:
- Providing clear, science-based, information;
- Supporting the efforts of member companies developing treatments, vaccines and other COVID-19 modalities;
- Assisting the bio/med industry as it deals with interruptions to the supply chain, travel restrictions, and workforce related issues; and
- Being a responsible actor at events we host and attend.
While much has happened over the week, our resolve and commitment to these principles has not waivered. We have concluded that being a responsible actor means we must postpone currently scheduled in-person events. This has been a difficult, but necessary decision. We are exploring alternative platforms for delivering content and will soon announce our plan for how you may access our educational and business development resources.
Our government relations team has been in regular contact with our members and public leaders to explore ways that we can assist New York State in its efforts to diagnose, treat, and contain the spread of COVID-19. I encourage you to consider ways that your organization can help. We’re here to connect you to the people and teams leading these efforts.
The implications of the pandemic on your business are significant and quickly evolving. Our legal partner, Barclay Damon, is presenting a webinar at 10:00 am this Monday, March 16, 2020 entitled “Coronavirus and the Workplace.” You may find a link here.
Additional links for updates and guidance may be found here:
Below are relevant articles regarding the Coronavirus:
Regeneron CEO hopes to have coronavirus treatment ready for human testing possibly by this summer.
MedTech Responds to the Coronovirus, 3/6/2020